Novel approaches for the treatment of prostate cancer
Therapeutic vaccines for prostate cancer
TGF-β signaling dictates therapeutic targeting in prostate cancer
Study suggests more than a third of prostate cancer patients are receiving contraindicated treatment
Obese men may be in danger of receiving an inaccurate prostate cancer diagnosis
New findings suggest high intensity focused ultrasound treatment is an effective treatment for prostate cancer
New study reveals potential for a novel compound in the treatment of prostate cancer
Risk of death from cardiovascular disease may be increased by prostate cancer therapy
Trial Watch
Diagnostic Watch
Research Highlights
Treatment ‘mismatch’ in early prostate cancer
Surgical and biologic outcomes after neoadjuvant bicalutamide treatment in prostate cancer
A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer
Adaptive therapy for androgen-independent prostate cancer
Preliminary results of the Prostacox Phase II trial in hormonal refractory prostate cancer
Avoiding surgery in prostate cancer patients with low-risk disease
Salvage cryotherapy for recurrent prostate cancer after radiation failure
New directions in endocrine therapy
Castrate-resistant prostate cancer
Osteoclast-targeted therapy for metastatic prostate cancer
Ibuprofen shows a slow in the decline of lung function in cystic fibrosis patients
Relief from vulvodynia with physical therapy
Novel biomarker helps identify high-risk ACS patients earlier
Patients suffering severe forms of migraines could be helped by genetic testing
Ultrasound-guided percutaneous therapy relieves shoulder pain
New ablation technique successful in the treatment of Barrett's esophagus
Recombinant human epoetin beta in the treatment of renal anemia
Hyperbaric oxygen therapy in the management of nonhealing wounds in patients with critical limb ischemia
Eating disorders related to obesity